Servio Dialysis Clinix Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-01-2025
- Paid Up Capital ₹ 0.10 M
as on 21-01-2025
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.23 Cr
as on 21-01-2025
- Satisfied Charges ₹ 1.20 Cr
as on 21-01-2025
- Revenue 48.49%
(FY 2023)
- Profit 111.19%
(FY 2023)
- Ebitda 30.37%
(FY 2023)
- Net Worth 102.18%
(FY 2023)
- Total Assets 20.22%
(FY 2023)
About Servio Dialysis Clinix
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.23 Cr. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Smriti Jain and Girish Sharma serve as directors at the Company.
- CIN/LLPIN
U85320DL2018PTC342809
- Company No.
342809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Servio Dialysis Clinix?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Sharma  | Director | 15-Dec-2019 | Current |
| Smriti Jain | Director | 10-Dec-2018 | Current |
Financial Performance of Servio Dialysis Clinix.
Servio Dialysis Clinix Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.49% increase. The company also saw a substantial improvement in profitability, with a 111.19% increase in profit. The company's net worth Soared by an impressive increase of 102.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Servio Dialysis Clinix?
Unlock access to Servio Dialysis Clinix's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹42.33 M
₹12.00 M
Charges Breakdown by Lending Institutions
- Others : 4.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2023 | Others | ₹2.04 M | Open |
| 30 Apr 2022 | Others | ₹2.04 M | Open |
| 28 Feb 2022 | Others | ₹4.01 M | Open |
| 21 Dec 2021 | Others | ₹2.10 M | Open |
| 20 Dec 2021 | Others | ₹3.65 M | Open |
How Many Employees Work at Servio Dialysis Clinix?
Servio Dialysis Clinix has a workforce of 31 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Servio Dialysis Clinix, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Servio Dialysis Clinix's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
